Form 8-K - Current report:
SEC Accession No. 0001558370-22-004997
Filing Date
2022-04-01
Accepted
2022-04-01 08:18:56
Documents
14
Period of Report
2022-04-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrbo-20220401x8k.htm   iXBRL 8-K 38376
2 EX-99.1 nrbo-20220401xex99d1.htm EX-99.1 118177
3 GRAPHIC nrbo-20220401xex99d1001.jpg GRAPHIC 4739
  Complete submission text file 0001558370-22-004997.txt   293077

Data Files

Seq Description Document Type Size
4 EX-101.SCH nrbo-20220401.xsd EX-101.SCH 3064
5 EX-101.LAB nrbo-20220401_lab.xml EX-101.LAB 15933
6 EX-101.PRE nrbo-20220401_pre.xml EX-101.PRE 10076
8 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20220401x8k_htm.xml XML 4832
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 22795902
SIC: 2834 Pharmaceutical Preparations